DMAAU
Drugs Made In America Acquisition Corp. UnitsNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$308.64M
P/E Ratio
—
EPS
—
Beta
—
52W High
$12.50
52W Low
$10.26
50-Day MA
$10.56
200-Day MA
$10.53
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. Units (DMAAU) is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative companies in the pharmaceutical and healthcare sectors. With a management team experienced in navigating and thriving within these industries, DMAAU is poised to facilitate significant growth and improve the accessibility of medications in the United States. As the emphasis on domestic drug production escalates, DMAAU offers institutional investors a timely opportunity to engage with the transformative trends towards innovation and affordability in healthcare.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.46% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.21 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $29.17M |
| Float | $27.31M |
| % Insiders | 17.88% |
| % Institutions | 1.54% |
Historical Volatility
HV 10-Day
14.95%
HV 20-Day
10.57%
HV 30-Day
8.63%
HV 60-Day
6.98%
HV Rank
76.2%
Volatility is currently expanding
More FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026